Medication Monitor



Generic Name (Trade Name—Company)
Notes
July 21, 2011

IncobotulinumtoxinA

(Xeomin—Merz Aesthetics)
Now for aesthetic use

Uses:

Temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients 

Merz Aesthetics announced the FDA approval of this product for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines. Approval was based on data from 547 healthy adult patients that showed that injection of the drug significantly improved the appearance of glabellar lines within 30 days of the first treatment compared with placebo. IncobotulinumtoxinA is also indicated for treatment of adults with cervical dystonia or blepharospasm. The product will be available nationwide for aesthetic use in spring 2012, according to the manufacturer.